We take a look at some of the exciting diabetes research developments announced in August, and what the findings could mean for people living with or affected by diabetes.
The drug manufacturer Novo Nordisk has announced it will withdraw Levemir insulin in all forms by the end of 2026. Here, we look at what this means for people with diabetes who are affected, and what ...
Our new stigma research looks at diabetes stigma at scale across the UK. With blame, shame and stigma staggeringly high across type 1 diabetes and type 2 diabetes – what can be done to tackle it?
We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.
In partnership with Tesco, we surveyed 2,000 people to get an insight into people’s understanding and awareness of diabetes.
Our research has provided the most detailed picture yet of how weight loss improves health. The findings offer important clues about how losing weight can help people with type 2 diabetes improve ...
On Thursday 3 July the government published its 10 Year Health Plan, setting out its ambition to rebuild the NHS and bring care closer to home.
There’s evidence that common viral infections in children may play a part in triggering the immune system attack at the root of type 1 diabetes. But we don’t yet understand how or why only some ...
The Bukhman Foundation has today announced a historic £100 million pledge to fund groundbreaking research that will accelerate progress towards new treatments and a cure for type 1 diabetes. Save for ...
The main treatment for type 1 diabetes is insulin - but carb counting, eating well, activity and diabetes tech can help you manage your blood sugar levels ...
Our new data shows that an urgent intervention is needed in diabetes care and type 2 diabetes prevention to lower the number of people living with diabetes or prediabetes. Save for later Page saved!
Some people who have followed a Mediterranean diet have lost weight and gone into type 2 diabetes remission. Find out more here.